title: [Therapy on mycoses after simultaneous pancreas-kidney transplantation].
abstract: Patients suffering from type I diabetes mellitus have a descending expectancy of life, after developing diabetic nephropathy and undergoing haemodialysis. After 3 years of haemodialysis, approximately only 40% of the patients are still alive. The only remedy of this incurable metabolic disease is the simultaneous pancreas-kidney transplantation. After transplantation, fungal colonization and fungal infection is a serious threat for the patient's life. In this context, it is necessary to distinguish between colonization and invasive mycosis. In the case of unsuccessful antimycotic treatment, the removal of the transplanted organ, depending on the patient's condition, may be necessary to save the patient's life.
authors.affiliation: Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein, D-23538 Lübeck, Germany. ralf.bouchard@chirurgie.uni-luebeck.de
authors.forename: R
authors.initials: R
authors.lastname: Bouchard
authors.forename: L
authors.initials: L
authors.lastname: Hennings
authors.forename: Th
authors.initials: T
authors.lastname: Jungbluth
authors.forename: I
authors.initials: I
authors.lastname: Klempien
authors.forename: P
authors.initials: P
authors.lastname: Kujath
authors.forename: H-P
authors.initials: HP
authors.lastname: Bruch
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D016035:Pancreas Transplantation / Q000009:adverse effects* / Q000379:methods; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000935:Antifungal Agents